Small molecule mimetics of an interferon-α receptor interacting domain

  • Bioorg Med Chem. 2014 Feb 1;22(3):978-85. doi: 10.1016/j.bmc.2013.12.049.
Angelica M Bello  1 Lianhu Wei  1 Beata Majchrzak-Kita  2 Noruê Salum  3 Meena K Purohit  4 Eleanor N Fish  5 Lakshmi P Kotra  6
Affiliations
  • 1. Center for Molecular Design and Preformulations, University Health Network, Toronto, Ontario M5G 1L7, Canada; Toronto General Research Institute, Toronto, Ontario M5G 2M1, Canada; Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada.
  • 2. Toronto General Research Institute, Toronto, Ontario M5G 2M1, Canada.
  • 3. Center for Molecular Design and Preformulations, University Health Network, Toronto, Ontario M5G 1L7, Canada; Federal University of Paraná, Curitiba, Paraná, Brazil.
  • 4. Center for Molecular Design and Preformulations, University Health Network, Toronto, Ontario M5G 1L7, Canada; Department of Pharmacy, Birla Institute of Technology & Science, Pilani 333 031, India.
  • 5. Toronto General Research Institute, Toronto, Ontario M5G 2M1, Canada; Department of Immunology, University of Toronto, Toronto, Canada.
  • 6. Center for Molecular Design and Preformulations, University Health Network, Toronto, Ontario M5G 1L7, Canada; Toronto General Research Institute, Toronto, Ontario M5G 2M1, Canada; Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada; McLaughlin Center for Molecular Medicine, University of Toronto, Toronto, Ontario, Canada. Electronic address: [email protected].
Abstract

Small molecules that mimic IFN-α epitopes that interact with the cell surface receptor, IFNAR, would be useful therapeutics. One such 8-amino acid region in IFN-α2, designated IRRP-1, was used to derive 11 chemical compounds that belong to 5 distinct chemotypes, containing the molecular features represented by the key residues Leu30, Arg33, and Asp35 in IRRP-1. Three of these compounds exhibited potential mimicry to IRRP-1 and, in cell based assays, as predicted, effectively inhibited IFNAR activation by IFN-α. Of these, compound 3 did not display cell toxicity and reduced IFN-α-inducible STAT1 phosphorylation and STAT-DNA binding. Based on physicochemical properties' analyses, our data suggest that moieties with acidic PKA on the small molecule may be a necessary element for mimicking the carboxyl group of Asp35 in IRRP-1. Our data confirm the relevance of this strategy of molecular mimicry of ligand-receptor interaction domains of protein partners for small molecule drug discovery.

Keywords
IFN-α receptor; Interferon; Peptidomimetics.
Products